Adma Biologics (ADMA) Debt Ratio (2016 - 2025)
Adma Biologics' Debt Ratio history spans 13 years, with the latest figure at 0.12 for Q4 2025.
- For Q4 2025, Debt Ratio fell 21.93% year-over-year to 0.12; the TTM value through Dec 2025 reached 0.12, down 21.93%, while the annual FY2025 figure was 0.12, 21.93% down from the prior year.
- Debt Ratio reached 0.12 in Q4 2025 per ADMA's latest filing, down from 0.13 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.47 in Q2 2022 to a low of 0.12 in Q4 2025.
- Average Debt Ratio over 5 years is 0.33, with a median of 0.4 recorded in 2021.
- Peak YoY movement for Debt Ratio: surged 459.41% in 2021, then crashed 62.69% in 2024.
- A 5-year view of Debt Ratio shows it stood at 0.34 in 2021, then rose by 19.36% to 0.41 in 2022, then fell by 3.21% to 0.4 in 2023, then plummeted by 62.69% to 0.15 in 2024, then dropped by 21.93% to 0.12 in 2025.
- Per Business Quant, the three most recent readings for ADMA's Debt Ratio are 0.12 (Q4 2025), 0.13 (Q3 2025), and 0.13 (Q2 2025).